Neko Health, the preventative healthcare technology company co-founded by Hjalmar Nilsonne and Daniel Ek (founder of Spotify), has established itself as a pioneer in the wellness space with its UK location in Marylebone, London. The Neko Health London centre offers cutting-edge body scanning technology to the capital, delivering comprehensive health assessments in minutes rather than months.
Since expanding outside Sweden, the company has built a strong reputation for its innovative approach to preventative care. With a waitlist that quickly grew to exceed 50,000 individuals eager to experience Neko Health London’s services, it’s clear this concept represents a significant shift in how we approach personal wellbeing through technology.
A new era of proactive health monitoring
The concept behind Neko Health London is refreshingly straightforward: provide people with detailed insights into their health before problems arise. Located at 9 St Vincent Street, the sleek Marylebone facility offers the company’s signature full-body scan for £299.
“In the UK, you are required to do an MOT on your car. However, when it comes to your body, you often need to break down before seeing a doctor,” explains Nilsonne, highlighting the reactive nature of traditional healthcare. “Our healthcare systems were designed decades ago; they haven’t kept pace with rising costs or demand – a trend that we collectively need to find a way to reverse.”
The Neko Body Scan uses over 70 sensors to collect an astonishing 50 million data points from each person. This comprehensive assessment checks for skin conditions (including potential skin cancer), cardiovascular disease markers, metabolic syndrome indicators, blood abnormalities, and more – all completed in approximately 10-15 minutes.
From Stockholm to London: Meeting overwhelming demand
View this post on Instagram
The London launch follows Neko Health’s successful debut in Stockholm, where appointment slots sold out within two hours of opening. The company has already built a waitlist exceeding 50,000 people eager to experience their technology in the UK, demonstrating significant interest in this innovative approach to healthcare.
What makes the experience particularly appealing is the elimination of anxious waiting periods. After the brief scan, members receive an immediate consultation with a Neko Health doctor who personally reviews the results and addresses any questions. All medical diagnoses and decisions are made by the doctor, maintaining the crucial human element in the healthcare journey.
More than a health check: Creating baseline data for future wellbeing
The impact of Neko Health’s approach is already evident. In its first year of operation in 2023, the company scanned 2,707 people in Sweden. While most (78.5%) had no immediate health concerns, 14.1% required medical treatment, and 1% received potentially life-saving interventions for serious conditions they were previously unaware of.
Perhaps most surprising was that 26% of those receiving life-saving treatment were under 50 years old, challenging the notion that comprehensive health screening is only necessary for older individuals.
Members gain access to their health data through a dedicated app, where they can track results over time and share findings with their NHS GP if desired. This longitudinal approach to health monitoring allows for more personalised care and earlier interventions when changes occur.
The future of luxury healthcare
View this post on Instagram
Neko Health represents a growing trend of premium services that prioritise prevention and convenience. The company aims to become the world’s most personalised preventative healthcare service, with plans for expansion across Europe following its London debut.
For those seeking the reassurance of comprehensive health monitoring without the traditional hassle of multiple appointments and extended waiting times, Neko Health London offers an intriguing glimpse into the future of healthcare – one where technology and human expertise combine to keep us well, rather than simply treating illness after it develops.
